Cargando…
Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation
BACKGROUND: Despite the use of combination antiretroviral therapy for the treatment of HIV-1 infection, cognitive impairments remain prevalent due to persistent viral replication and associated brain inflammation. Primary cellular targets of HIV-1 in the brain are macrophages, microglia, and to a ce...
Autores principales: | Omeragic, Amila, Hoque, Md Tozammel, Choi, U-yeong, Bendayan, Reina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591559/ https://www.ncbi.nlm.nih.gov/pubmed/28886715 http://dx.doi.org/10.1186/s12974-017-0957-8 |
Ejemplares similares
-
Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders
por: Omeragic, Amila, et al.
Publicado: (2020) -
Peroxisome Proliferator-Activated Receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model
por: Omeragic, Amila, et al.
Publicado: (2019) -
Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function
por: Huang, Chang, et al.
Publicado: (2023) -
Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation
por: Ashraf, Tamima, et al.
Publicado: (2014) -
Novel localization of folate transport systems in the murine central nervous system
por: Sangha, Vishal, et al.
Publicado: (2022)